Addendum: Cost of Ustekinumab (Stelara)

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1333

March 8, 2010

View Complete Issue Table of Contents 2019

Addendum: Cost of Ustekinumab (Stelara)

Download PDF: US English

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2010 Mar 8;52(1333):20

Disclosures

Objective(s)

Select a term to see related articles 2010 2010 Page 7 adalimumab Addendum: Cost of Ustekinumab (Stelara) (Med Lett Drugs Ther 2010; 52:7) Alefacept Amevive Biologics Calcipotriene Calcitriol corticosteroids Cost of Ustekinumab Cost of Ustekinumab (Stelara) cyclosporine Dovonex Enbrel etanercept Humira infliximab Interleukin antagonist Issue 1330 Issue 1333 January 25 March 8 methotrexate page 20 phototherapy plaque psoriasis Remicade Stelara tazarotene Tazorac ustekinumab Ustekinumab (Stelara) for Psoriasis Vectical volume 52

In the Medical Letter article on ustekinumab (Stelara) for psoriasis (2010; 52:7), footnote 2 in table 2 should have included a second sentence: $5595.60 is the cost of one 45-mg syringe.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.